Cel Humans have two ears – and for good reason: So-called binaural hearing is critical not only for localizing acoustic events but also for selectively focusing on a target sound while suppressing sound from other directions. In order to perform these tasks, neural circuits with the most temporally precise processing within the entire nervous system have evolved.360 million people have impaired hearing. Although hearing aids and cochlear implants help restore audibility, they provide insufficient benefit in restoring the advantages of true binaural hearing.IBiDT is designed to fundamentally change this perspective. Appreciating the individual nature of each hearing deficit, it will provide the means of diagnosing pathologies, not just the perceptual symptoms. IBiDT will suggest algorithms specific to the individual detailed patient profile and suggest therapeutic interventions specific to the listening situation. To achieve these aims, a multidisciplinary approach in which both auditory and non-auditory aspects of patient profiles and a computer model simulating the impaired auditory system will, together, transform diagnosis of hearing impairment from one concerned with audibility to one concerned with effective communication in any listening environment. Binaural hearing is an ideal conceptual framework in which to investigate this approach as it increases greatly the number of possible pathologies, compared to unilateral diagnostics.The binaural hearing system is also ideal to investigate because it allows for large improvements in listening performance. Despite significant R&D expenditure, cochlear-implant performance has plateaued over the last 15 years, at least with respect to unilateral devices. Improvements from Individualized Binaural Diagnosis and Technology will have a large, positive impact on the increasing number of bilateral cochlear implant users (many of them children), as well as on the many tens of millions of people who use hearing aids. Dziedzina nauki natural sciencesbiological sciencesneurobiologymedical and health scienceshealth sciencesinfectious diseasesRNA virusesHIVmedical and health sciencesbasic medicinepathologymedical and health sciencesmedical biotechnologyimplants Program(-y) H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC) Main Programme Temat(-y) ERC-2016-STG - ERC Starting Grant Zaproszenie do składania wniosków ERC-2016-STG Zobacz inne projekty w ramach tego zaproszenia System finansowania ERC-STG - Starting Grant Instytucja przyjmująca CARL VON OSSIETZKY UNIVERSITAET OLDENBURG Wkład UE netto € 1 500 000,00 Adres AMMERLAENDER HEERSTRASSE 114-118 26129 Oldenburg Niemcy Zobacz na mapie Region Niedersachsen Weser-Ems Oldenburg (Oldenburg), Kreisfreie Stadt Rodzaj działalności Higher or Secondary Education Establishments Linki Kontakt z organizacją Opens in new window Strona internetowa Opens in new window Uczestnictwo w unijnych programach w zakresie badań i innowacji Opens in new window sieć współpracy HORIZON Opens in new window Koszt całkowity € 1 500 000,00 Beneficjenci (1) Sortuj alfabetycznie Sortuj według wkładu UE netto Rozwiń wszystko Zwiń wszystko CARL VON OSSIETZKY UNIVERSITAET OLDENBURG Niemcy Wkład UE netto € 1 500 000,00 Adres AMMERLAENDER HEERSTRASSE 114-118 26129 Oldenburg Zobacz na mapie Region Niedersachsen Weser-Ems Oldenburg (Oldenburg), Kreisfreie Stadt Rodzaj działalności Higher or Secondary Education Establishments Linki Kontakt z organizacją Opens in new window Strona internetowa Opens in new window Uczestnictwo w unijnych programach w zakresie badań i innowacji Opens in new window sieć współpracy HORIZON Opens in new window Koszt całkowity € 1 500 000,00